Sg3 Management, LLC Amicus Therapeutics, Inc. Put Options Transaction History

Sg3 Management, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $197,800 - $254,000	20,000 New	20,000 $244,000
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $118,350 - $187,200	15,000 New	15,000 $142,000
Q4 2021 Feb 15, 2022	SELL	$9.82 - $12.44 $275,942 - $349,564	-28,100 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $27,094 - $36,704	3,100 Added 12.4%	28,100 $268,000
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $1.88 Million - $2.32 Million	-216,200 Reduced 89.64%	25,000 $241,000
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $2.58 Million - $4.76 Million	191,200 Added 382.4%	241,200 $5.57 Million
Q3 2020 Nov 13, 2020	BUY	$12.89 - $15.89 $644,500 - $794,500	50,000 New	50,000 $706,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.